Compare Boston Scientific Corporation (BSX) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs Citius Pharmaceuticals Inc — how do they compare? Boston Scientific Corporation trades at $42.6 (market cap $66.37B), while Citius Pharmaceuticals Inc trades at $0.52 (market cap $14.83M). The key difference: Boston Scientific Corporation is far larger — about 4475.4× Citius Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| BSX | CTXR | |
|---|---|---|
Market Cap | $66.37B | $14.83M |
Sector | Health | Health |
52-Week High | $108.14 | $1.82 |
52-Week Low | $42.63 | $0.53 |
Enterprise Value | $75.94B | $11.05M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
